This is a condition where the kidneys become stiff and hard over time. It's often caused by high blood pressure or problems with the blood vessels leading to the kidneys. This stiffness can make it harder for the kidneys to filter waste from your blood, leading to kidney damage.
Every report comes from a Lived member, sent anonymously.
Have you tried Cozaar (Losartan) for Nephrosclerosis?
Nephrosclerosis is scarring and hardening inside the kidneys that develops when their small blood vessels are damaged, most often by high blood pressure over many years. The narrowed vessels deliver less blood to the kidneys' tiny filters, called glomeruli, and over time some filters and the tissue around them are replaced by scar. Doctors often call it hypertensive nephrosclerosis or hypertensive kidney disease, and it is a form of chronic kidney disease. The damage matters because the kidneys clean waste and extra fluid from the blood. As filters are lost, the kidneys do this less well. In the United States, high blood pressure is the second leading cause of kidney failure after diabetes. Early on, nephrosclerosis usually causes no symptoms, so it is typically found through blood and urine tests rather than because someone feels unwell. A rarer and more dangerous form, sometimes called malignant nephrosclerosis, occurs with extremely high blood pressure (malignant hypertension) and can injure the kidneys quickly. It is a medical emergency treated in the hospital, quite different from the slow form this page mainly describes.
Long-standing high blood pressure is the main cause. Persistently high pressure thickens and narrows the small arteries that feed the kidneys, which reduces blood flow and gradually scars the filters. The relationship runs both ways: damaged kidneys hold on to extra salt and fluid, which pushes blood pressure higher and can speed further damage. Older age, hardening of the arteries (atherosclerosis), high cholesterol, obesity and smoking add to the injury. Diabetes often occurs alongside high blood pressure and causes its own kidney damage, so many people have a mix of both. Genetics plays a part too. Two variants of a gene called APOL1, found mainly in people with African ancestry, are strongly linked to kidney disease that has often been labeled hypertensive nephrosclerosis. In some of these people, the kidney disease appears to come first and raise blood pressure, rather than the other way round. A family history of kidney failure is another reason to have kidney health checked.
Nephrosclerosis is usually diagnosed from the overall picture rather than from a single test. A clinician typically suspects it when someone with years of high blood pressure is found to have reduced kidney function, only a small amount of protein in the urine and no sign of another kidney disease. Two tests track kidney health. A blood test estimates the glomerular filtration rate (GFR), a measure of how well the kidneys filter the blood, from a waste product called creatinine. A GFR of 60 or more is in the normal range, a GFR below 60 may mean kidney disease, and 15 or less is kidney failure. A urine test measures albumin, a protein that healthy kidneys keep in the blood. A urine albumin-to-creatinine ratio above 30 mg/g can signal kidney damage, and an abnormal result is usually repeated to confirm it. Blood pressure readings matter too. A reading has a top (systolic) number, the pressure as the heart beats, and a bottom (diastolic) number, the pressure between beats. In the US, high blood pressure is diagnosed when repeated readings show a top number of 130 or higher, a bottom number of 80 or higher, or both. An ultrasound may show kidneys that are smaller than usual. Because high blood pressure is so common, the label can hide another cause, such as diabetic kidney disease or APOL1-related kidney disease. When the picture is unclear, especially in someone who also has diabetes, a kidney biopsy (a small tissue sample taken with a needle) is the most reliable way to show which process is driving the damage.
Treatment cannot undo scarring that has already formed, but it can slow further loss of kidney function. Lowering blood pressure is the most important step. Two related groups of blood pressure medicines are usually preferred: angiotensin-converting enzyme (ACE) inhibitors (such as ramipril) and angiotensin receptor blockers, or ARBs (such as losartan). Besides lowering blood pressure, they reduce the pressure inside the kidney's filters and cut down protein leakage. In a large US trial of Black adults with kidney disease from high blood pressure, treatment based on ramipril slowed kidney decline more than treatment based on a beta-blocker or a calcium channel blocker. Many people need two or more medicines, often including a diuretic (water pill). These medicines can raise blood potassium, which is already a common problem in kidney disease, so blood tests are part of follow-up. The right blood pressure goal is set individually. An international kidney guideline (KDIGO, Kidney Disease: Improving Global Outcomes) suggests aiming for a top number below 120 when that can be reached safely, while other guidelines use a goal below 130/80. Pushing pressure lower is linked to more sudden drops in kidney function and shifts in blood salts, so age, other conditions and how a person tolerates treatment shape the target. Some people with chronic kidney disease are also offered dapagliflozin (Farxiga), a pill from a group called SGLT2 (sodium-glucose cotransporter 2) inhibitors that is also used for type 2 diabetes. It is approved to lower the risk of further kidney decline, kidney failure and death from heart disease in adults with chronic kidney disease that is at risk of getting worse. Daily habits support the medicines: eating less sodium (kidney guidelines suggest under 2 grams a day), about 150 minutes a week of moderate activity, working toward a healthier weight and stopping smoking. Because the same blood vessel damage raises the risk of heart attack and stroke, managing other heart risks matters too. If the kidneys eventually fail, dialysis or a kidney transplant takes over their work.
Nephrosclerosis usually progresses slowly, often over years, and many people feel well for a long time. Kidney disease from high blood pressure tends to progress more slowly than kidney disease from diabetes, though the pace varies from person to person. Blood pressure control is the part people can most influence. Lost filtering capacity does not usually come back, so the aim is to keep GFR from falling further and to keep urine albumin stable or lower. Follow-up typically means regular blood and urine tests, blood pressure checks at home and in the clinic, and medicine adjustments over time. Many people take more than one daily medicine and pay attention to salt in their diet. If kidney function keeps falling, planning for dialysis or a transplant becomes part of care, and a kidney specialist (nephrologist) usually becomes involved. Heart and blood vessel health remains a lifelong part of care, because the process that scars the kidneys also strains the heart and brain.
If you have high blood pressure, ask your clinician how often your kidneys should be checked with blood and urine tests, especially if you also have diabetes, heart disease or a family history of kidney failure. Contact your care team if home readings stay above your agreed target, or if you develop new swelling in your legs, ankles or feet, ongoing nausea or poor appetite, itching or unusual tiredness, since these can mean kidney function or blood pressure control is getting worse. Call 911 if very high blood pressure comes with symptoms such as a severe headache, blurred vision, confusion or unusual drowsiness, chest pain or pressure, shortness of breath, numbness or weakness in the face, arms or legs, a seizure, or much less urine than usual. These can be signs of malignant hypertension, which can quickly damage the kidneys, brain, heart and eyes.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Nephrosclerosis is like, what's helped you, or ask the community a question.